AtriCure, Inc.
ATRC
$28.83
$0.040.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.01% | 14.88% | 15.80% | 16.28% | 15.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.01% | 14.88% | 15.80% | 16.28% | 15.79% |
| Cost of Revenue | 11.14% | 13.56% | 15.41% | 16.89% | 18.15% |
| Gross Profit | 16.32% | 15.32% | 15.94% | 16.07% | 15.02% |
| SG&A Expenses | 8.28% | 6.75% | 6.27% | 8.95% | 11.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.76% | 7.65% | 13.09% | 14.89% | 15.28% |
| Operating Income | 91.53% | 76.39% | 22.53% | 2.20% | -8.75% |
| Income Before Tax | 91.21% | 76.73% | 26.37% | 10.17% | -1.54% |
| Income Tax Expenses | 23.33% | 25.49% | -16.27% | 27.10% | 55.17% |
| Earnings from Continuing Operations | 87.97% | 74.39% | 26.07% | 9.38% | -2.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 87.97% | 74.39% | 26.07% | 9.38% | -2.54% |
| EBIT | 91.53% | 76.39% | 22.53% | 2.20% | -8.75% |
| EBITDA | 213.18% | 152.09% | 61.36% | 19.96% | 1.40% |
| EPS Basic | 88.09% | 74.67% | 26.93% | 10.62% | -1.21% |
| Normalized Basic EPS | 91.28% | 76.23% | 24.49% | 8.23% | -2.86% |
| EPS Diluted | 88.00% | 74.60% | 26.93% | 10.62% | -1.21% |
| Normalized Diluted EPS | 91.14% | 76.12% | 24.49% | 8.23% | -2.86% |
| Average Basic Shares Outstanding | 1.80% | 1.67% | 1.59% | 1.53% | 1.45% |
| Average Diluted Shares Outstanding | 2.67% | 2.16% | 1.59% | 1.53% | 1.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |